Immature platelet fraction as a clinical predictor for enhanced platelet recovery in patients with dengue fever
en-GBde-DEes-ESfr-FR

Immature platelet fraction as a clinical predictor for enhanced platelet recovery in patients with dengue fever

18/03/2025 Frontiers Journals

Dengue fever's clinical progression is closely tied to platelet dynamics, yet predicting recovery remains challenging. Immature platelet fraction (IPF) is recognized as a marker for thrombopoiesis, but its role in dengue has been underexplored. This finding indicates that IPF% can be utilized as a predictor of platelet increase in patients with dengue infection. Additionally, IPF has been used as a marker to determine the etiology of thrombocytopenia, whether it is caused by excessive platelet destruction or decreased platelet production in the bone marrow, as observed in patients with dengue infection. These findings suggest that IPF can be utilized as an additional predictive tool to monitor platelet recovery and identify the etiology of thrombocytopenia. However, it is important to note that recovery from dengue infection is not solely determined by platelet count. The restoration of platelet levels is merely one of the indicators of the recovery phase in dengue.

The work entitled “Immature platelet fraction as a clinical predictor for enhanced platelet recovery in patients with dengue fever” was published on One Health Bulletin (published on Feb. 27, 2025).
DOI: 10.4103/ohbl.ohbl_48_24
Reference: Somia IKA, Purnamasidhi CAW, Shanti DAFP, Purnama GV, Adiputra IKH. Immature platelet fraction as a clinical predictor for enhanced platelet recovery in patients with dengue fever. One Health Bull 2025; https://doi:10.4103/ohbl.ohbl_48_24
18/03/2025 Frontiers Journals
Regions: Asia, China
Keywords: Health, Medical

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Testimonios

We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet
AlphaGalileo is a great source of global research news. I use it regularly.
Robert Lee Hotz, LA Times

Trabajamos en estrecha colaboración con...


  • BBC
  • The Times
  • National Geographic
  • The University of Edinburgh
  • University of Cambridge
  • iesResearch
Copyright 2025 by DNN Corp Terms Of Use Privacy Statement